Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma (Q33358885)

26 July 2017

Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma (English)

1 reference

26 July 2017

1 reference

Andrea B Troxel

6

0 references

Dawn L. Hershman

3

object named as

Dawn L Hershman

1 reference

26 July 2017

Amy D Tiersten

1

1 reference

26 July 2017

Meredith J Selleck

2

1 reference

26 July 2017

D Smith

4

1 reference

26 July 2017

Edward E Resnik

5

1 reference

26 July 2017

Lois B Brafman

7

1 reference

26 July 2017

Laureen Shriberg

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

26 July 2017

1 reference

26 July 2017

92

1 reference

26 July 2017

2

1 reference

26 July 2017

635-638

1 reference

26 July 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Synergistic interaction between topotecan and microtubule-interfering agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.11.019

10.1016/J.YGYNO.2003.11.019

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference